RU2010130355A - MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF ORGANIC DISEASES OF THE NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHY OF VARIOUS GENESIS - Google Patents
MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF ORGANIC DISEASES OF THE NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHY OF VARIOUS GENESIS Download PDFInfo
- Publication number
- RU2010130355A RU2010130355A RU2010130355/15A RU2010130355A RU2010130355A RU 2010130355 A RU2010130355 A RU 2010130355A RU 2010130355/15 A RU2010130355/15 A RU 2010130355/15A RU 2010130355 A RU2010130355 A RU 2010130355A RU 2010130355 A RU2010130355 A RU 2010130355A
- Authority
- RU
- Russia
- Prior art keywords
- antibodies
- activated
- aqueous
- potentiated
- endothelial
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
1. Лекарственное средство для лечения органических заболеваний нервной системы, психоорганического синдрома и энцефалопатий различного генеза, содержащее активированную-потенцированную форму антител к мозгоспецифическому белку S-100, характеризующееся тем, что выполнено в виде фармацевтической композиции и содержит в качестве дополнительного-усиливающего компонента активированную-потенцированную форму антител к эндотелиальной NO-синтазе. ! 2. Лекарственное средство по п.1, характеризующееся тем, что активированную-потенцированную форму антител к эндотелиальной NO-синтазе и активированную-потенцированную форму антител к мозгоспецифическому белку S-100 используют в виде активированного-потенцированного водного или водно-спиртового раствора, активность которого обусловлена процессом последовательного многократного разведения в водном или водно-спиртовом растворителе в сочетании с внешним механическим воздействием - вертикальным встряхиванием каждого разведения. ! 3. Лекарственное средство по п.1 или 2, характеризующееся тем, что фармацевтическая композиция выполнена в твердой лекарственной форме и содержит эффективное количество гранул нейтрального носителя, насыщенного смесью водных или водно-спиртовых растворов активированной-потенцированной формы антител к эндотелиальной NO-синтазе и активированной-потенцированной формы антител к мозгоспецифическому белку S-100, и фармацевтически приемлемые добавки. ! 4. Лекарственное средство по п.1 или 2, характеризующееся тем, что водные или водно-спиртовые растворы активированных потенцированных форм антител к эндотелиальной NO-синтазе и к мозгоспецифическ� 1. A medicine for the treatment of organic diseases of the nervous system, psycho-organic syndrome and encephalopathies of various genesis, containing an activated-potentiated form of antibodies to the brain-specific protein S-100, characterized in that it is made in the form of a pharmaceutical composition and contains an activated- potentiated form of antibodies to endothelial NO synthase. ! 2. The drug according to claim 1, characterized in that the activated-potentiated form of antibodies to endothelial NO synthase and the activated-potentiated form of antibodies to brain-specific protein S-100 are used in the form of an activated-potentiated aqueous or aqueous-alcoholic solution, the activity of which due to the process of successive multiple dilutions in an aqueous or hydroalcoholic solvent in combination with an external mechanical action - vertical shaking of each dilution. ! 3. The drug according to claim 1 or 2, characterized in that the pharmaceutical composition is made in solid dosage form and contains an effective amount of granules of a neutral carrier saturated with a mixture of aqueous or aqueous-alcoholic solutions of an activated-potentiated form of antibodies to endothelial NO synthase and activated -potentiated forms of antibodies to the brain-specific protein S-100, and pharmaceutically acceptable additives. ! 4. The drug according to claim 1 or 2, characterized in that the aqueous or aqueous-alcoholic solutions of activated potentiated forms of antibodies to endothelial NO synthase and to brain-specific
Claims (9)
Priority Applications (37)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010130355/15A RU2530638C2 (en) | 2010-07-21 | 2010-07-21 | Medication and method of treating organic diseases of nervous system, psychoorganic syndrome and encephalopathies of different genesis |
JP2013519175A JP2013538186A (en) | 2010-07-15 | 2011-07-15 | Method for increasing the effect of activation-enhancing antibodies |
FR1156481A FR2962914A1 (en) | 2010-07-21 | 2011-07-15 | PHARMACEUTICAL COMPOSITION FOR USE IN A PROCESS FOR TREATING NERVOUS SYSTEM ORGANIC DISEASES, PSYCHO-ORGANIC SYNDROME AND ENCEPHALOPATHY |
CZ20130105A CZ2013105A3 (en) | 2010-07-15 | 2011-07-15 | Method of increasing effect of antibody activated potentiated form |
PCT/IB2011/002350 WO2012007845A2 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
EA201300126A EA030566B1 (en) | 2010-07-15 | 2011-07-15 | Method of increasing therapeutic effectiveness of an activated-potentiated form of an antibody to an endogenous biological molecule and pharmaceutical composition |
ES201390006A ES2440393R1 (en) | 2010-07-15 | 2011-07-15 | A METHOD FOR INCREASING THE EFFECT OF A POTENTIATED ACTIVATED FORM OF AN ANTIBODY |
SG2013002324A SG187038A1 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
US13/135,896 US20120258146A1 (en) | 2010-07-21 | 2011-07-15 | Method of treating organic diseases of nervous system, pschoorganic syndrome and encephalopathy |
SG10201505561TA SG10201505561TA (en) | 2010-07-15 | 2011-07-15 | A Method Of Increasing The Effect Of An Activated-Potentiated Form Of An Antibody |
PE2013000076A PE20130398A1 (en) | 2010-07-15 | 2011-07-15 | A METHOD TO INCREASE THE EFFECT OF AN ACTIVE ENHANCED FORM OF AN ANTIBODY |
IT000634A ITTO20110634A1 (en) | 2010-07-21 | 2011-07-15 | METHOD FOR TREATING ORGANIC DISEASES OF THE NERVOUS SYSTEM, THE PSYCHOORGANIC SYNDROME AND THE SYNTHALOPATHY |
AU2011278038A AU2011278038B2 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
EP11775838.3A EP2593140A2 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
NZ606767A NZ606767A (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
EEP201300006A EE201300006A (en) | 2010-07-15 | 2011-07-15 | A pharmaceutical composition for enhancing the effect of an activated and potentiated form of an antibody |
MX2013000543A MX2013000543A (en) | 2010-07-15 | 2011-07-15 | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract. |
EP11775839.1A EP2596020A2 (en) | 2010-07-21 | 2011-07-15 | Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy |
SE1350184A SE1350184A1 (en) | 2010-07-15 | 2011-07-15 | PROCEDURE TO INCREASE THE EFFECT OF AN ACTIVATED, POTENTIZED FORM OF AN ANTIBODY |
GB1302649.7A GB2495884B (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
PCT/IB2011/002364 WO2012014078A2 (en) | 2010-07-21 | 2011-07-15 | Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy |
DE112011102358T DE112011102358T5 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
CA2804966A CA2804966A1 (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
FR1156482A FR2962656A1 (en) | 2010-07-15 | 2011-07-15 | METHOD FOR INCREASING THE EFFECT OF AN ACTIVATED-POTENTIALIZED FORM OF ANTIBODY |
KR1020137003861A KR20140014059A (en) | 2010-07-15 | 2011-07-15 | A method of increasing the effect of an activated-potentiated form of an antibody |
IT000639A ITTO20110639A1 (en) | 2010-07-15 | 2011-07-15 | METHOD TO INCREASE THE EFFECT OF AN ACTIVE-ENHANCED SHAPE OF AN ANTI-BODY |
US13/135,901 US9308275B2 (en) | 2010-07-15 | 2011-07-15 | Method of increasing the effect of an activated-potentiated form of an antibody |
BR112013000840A BR112013000840A2 (en) | 2010-07-15 | 2011-07-15 | method for enhancing the effect of potentiated activated form of antibody to biological endogenous molecule, pharmaceutical composition and use of combination of endogenous biological molecule with potentiated activated form of antibody to endothelial synthase. |
ARP110102578A AR082247A1 (en) | 2010-07-15 | 2011-07-18 | A METHOD FOR INCREASING THE EFFECTS OF A POTENTIATED ACTIVATED FORM OF AN ANTIBODY |
CL2013000099A CL2013000099A1 (en) | 2010-07-15 | 2013-01-10 | A method of increasing the effect of an potentiated active form of an antibody to an endogenous biological molecule, comprising the combination of the endogenous biological molecule with an enhanced active form of an endoltelial non-synthase antibody; composition that understands it. |
NO20130222A NO20130222A1 (en) | 2010-07-15 | 2013-02-08 | Process for increasing the effect of an activated-potentiated form of an antibody |
LT2013016A LT5988B (en) | 2010-07-15 | 2013-02-14 | A method of increasing the effect of an activated-potentiated form of an antibody |
DKPA201370079A DK201370079A (en) | 2010-07-15 | 2013-02-14 | A method of increasing the effect of an activated-potentiated form of an antibody |
FI20135143A FI20135143L (en) | 2010-07-15 | 2013-02-15 | A method of increasing the potency of an activated potentiated form of an antibody |
US15/060,202 US20160251448A1 (en) | 2010-07-15 | 2016-03-03 | Method of increasing the effect of an activated-potentiated form of an antibody |
US15/060,157 US20160244531A1 (en) | 2010-07-15 | 2016-03-03 | Method of increasing the effect of an activated-potentiated form of an antibody |
JP2016135750A JP2016216483A (en) | 2010-07-15 | 2016-07-08 | Method of increasing effect of activated-potentiated antibody |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010130355/15A RU2530638C2 (en) | 2010-07-21 | 2010-07-21 | Medication and method of treating organic diseases of nervous system, psychoorganic syndrome and encephalopathies of different genesis |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2010130355A true RU2010130355A (en) | 2012-01-27 |
RU2530638C2 RU2530638C2 (en) | 2014-10-10 |
Family
ID=45786202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010130355/15A RU2530638C2 (en) | 2010-07-15 | 2010-07-21 | Medication and method of treating organic diseases of nervous system, psychoorganic syndrome and encephalopathies of different genesis |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2530638C2 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6562629B1 (en) * | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
RU2156621C1 (en) * | 1999-03-04 | 2000-09-27 | Эпштейн Олег Ильич | Neurotropic drug |
-
2010
- 2010-07-21 RU RU2010130355/15A patent/RU2530638C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2530638C2 (en) | 2014-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2010133048A (en) | MEDICINAL PRODUCT AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS | |
JP2013538195A5 (en) | ||
RU2010133045A (en) | MEDICINAL PRODUCT AND METHOD FOR PREVENTION OF HIV INFECTION, PREVENTION AND TREATMENT OF DISEASES CAUSED BY HIV OR ASSOCIATED WITH HIV, INCLUDING AIDS | |
RU2011127059A (en) | NEUROTROPIC MEDICINE AND METHOD OF TREATMENT OF ORGANIC DISEASES OF THE NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHY OF VARIOUS GENESIS | |
RU2011127052A (en) | METHOD FOR TREATING THE HEAD-VARIABLE OF VARIOUS GENESIS, KINETOSIS AND VEGETOVASCULAR DYSTONIA (OPTIONS) AND MEDICINAL PRODUCT | |
RU2010133053A (en) | INTEGRATED MEDICINE FOR TREATMENT OF VIRAL DISEASES AND METHOD OF TREATMENT OF VIRAL DISEASES | |
RU2011127058A (en) | MEDICINE FOR TREATMENT OF ALZHEIMER'S DISEASE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | |
RU2010130355A (en) | MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF ORGANIC DISEASES OF THE NERVOUS SYSTEM, PSYCHOORGANIC SYNDROME AND ENCEPHALOPATHY OF VARIOUS GENESIS | |
RU2010130356A (en) | MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF VEGETO-VASCULAR DYSTONIA, VERTAIN SYNDROME OF VARIOUS GENESIS AND KINETOSIS | |
RU2011127055A (en) | MEDICINAL PRODUCT FOR TREATMENT OF NEUROLOGICAL-BEHAVIORAL DEVELOPMENT DISORDERS AND METHOD OF TREATMENT OF NEUROLOGICAL-BEHAVIORAL DISORDERS OF DEVELOPMENT | |
RU2013154070A (en) | METHOD FOR TREATMENT OF VEGETAIN-VASCULAR DISTONIA AND MEDICINAL PRODUCT | |
RU2010130358A (en) | MEDICINE FOR TREATMENT OF ATTENTION DEFICIENCY SYNDROME AND METHOD FOR TREATMENT OF ATTENTION DEFICIENCY SYNDROME | |
RU2010130353A (en) | MEDICINE FOR TREATMENT OF ALZHEIMER'S DISEASE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | |
RU2013154072A (en) | MEDICINE FOR TREATMENT OF KINETOSIS AND METHOD OF TREATMENT OF KINETOSIS | |
RU2013152871A (en) | DIABETES TREATMENT METHOD AND COMBINED MEDICINE | |
RU2013154071A (en) | MEDICINAL PRODUCT AND METHOD FOR TREATMENT OF HEAD-WAYS | |
RU2010129295A (en) | MEDICINAL PRODUCT FOR TREATING PROSTATE DISEASES AND METHOD FOR TREATING PROSTATE DISEASES | |
RU2010130350A (en) | METHOD FOR TREATING DEPENDENCE ON PSYCHOACTIVE SUBSTANCES, ALCOHOLISM AND TOBACCO SMOKING AND MEDICINAL PRODUCT FOR TREATING DEPENDENCE ON PSYCHOACTIVE SUBSTANCES, ALCOHOLISM AND TOBACCO SMOKING | |
RU2013154073A (en) | PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING A PATHOLOGICAL SYNDROME | |
RU2010133052A (en) | INTEGRATED MEDICINE FOR TREATMENT OF VIRAL INFECTIONS AND METHOD OF TREATMENT OF VIRAL INFECTIONS | |
RU2011124809A (en) | MEDICINE FOR TREATMENT OF PATHOLOGICAL SYNDROME AND METHOD FOR TREATING FUNCTIONAL INTESTINAL DISORDERS | |
RU2011127056A (en) | MEDICINAL PRODUCT FOR TREATMENT OF PATHOLOGICAL SYNDROME AND METHOD FOR TREATING MULTIPLE SCLEROSIS | |
RU2013152874A (en) | MEDICINE | |
RU2010129294A (en) | MEDICINE FOR TREATMENT OF ERECTILE DYSFUNCTIONS AND METHOD OF TREATMENT OF ERECTILE DYSFUNCTIONS | |
RU2010131386A (en) | MEDICINAL PRODUCT FOR TREATMENT OF INFECTIOUS DISEASES ASSOCIATED WITH NEUROTOXIC DISORDERS, AND METHOD FOR TREATMENT OF INFECTIOUS DISEASES ASSOCIATED WITH NEUROTOXIC DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20190722 |